These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7616116)

  • 1. Structural and functional differences of subspecies of apoA-I-containing lipoprotein in patients with plasma cholesteryl ester transfer protein deficiency.
    Ohta T; Nakamura R; Takata K; Saito Y; Yamashita S; Horiuchi S; Matsuda I
    J Lipid Res; 1995 Apr; 36(4):696-704. PubMed ID: 7616116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of high-density apolipoprotein particles A-I and A-I:A-II isolated from humans with cholesteryl ester transfer protein deficiency.
    Duverger N; Rader D; Ikewaki K; Nishiwaki M; Sakamoto T; Ishikawa T; Nagano M; Nakamura H; Brewer HB
    Eur J Biochem; 1995 Jan; 227(1-2):123-9. PubMed ID: 7851377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of subspecies of apolipoprotein A-I-containing lipoprotein in homozygotes for familial lecithin:cholesterol acyltransferase deficiency.
    Ohta T; Hattori S; Nakamura R; Horiuchi S; Frohlich J; Takata K; Ikeda Y; Saito Y; Matsuda I
    Arterioscler Thromb; 1994 Jul; 14(7):1137-45. PubMed ID: 8018670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects of purified apolipoproteins A-I, A-II, and A-IV on cholesteryl ester transfer protein activity.
    Guyard-Dangremont V; Lagrost L; Gambert P
    J Lipid Res; 1994 Jun; 35(6):982-92. PubMed ID: 8077854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender effects on the distribution of the cholesteryl ester transfer protein in apolipoprotein A-I-defined lipoprotein subpopulations.
    Moulin P; Cheung MC; Bruce C; Zhong S; Cocke T; Richardson H; Tall AR
    J Lipid Res; 1994 May; 35(5):793-802. PubMed ID: 8071602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesteryl Ester Transfer Protein Inhibition With Anacetrapib Decreases Fractional Clearance Rates of High-Density Lipoprotein Apolipoprotein A-I and Plasma Cholesteryl Ester Transfer Protein.
    Reyes-Soffer G; Millar JS; Ngai C; Jumes P; Coromilas E; Asztalos B; Johnson-Levonas AO; Wagner JA; Donovan DS; Karmally W; Ramakrishnan R; Holleran S; Thomas T; Dunbar RL; deGoma EM; Rafeek H; Baer AL; Liu Y; Lassman ME; Gutstein DE; Rader DJ; Ginsberg HN
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):994-1002. PubMed ID: 26966279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of subspecies of lipoprotein containing apolipoprotein A-I in heterozygotes for familial lecithin:cholesterol acyltransferase deficiency.
    Ohta T; Nakamura R; Frohlich JJ; Pritchard PH; Matsuda I
    Atherosclerosis; 1995 Apr; 114(2):147-55. PubMed ID: 7605383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular determinants of plasma cholesteryl ester transfer protein binding to high density lipoproteins.
    Bruce C; Davidson WS; Kussie P; Lund-Katz S; Phillips MC; Ghosh R; Tall AR
    J Biol Chem; 1995 May; 270(19):11532-42. PubMed ID: 7744792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different effects of subclasses of HDL containing apoA-I but not apoA-II (LpA-I) on cholesterol esterification in plasma and net cholesterol efflux from foam cells.
    Ohta T; Saku K; Takata K; Nakamura R; Ikeda Y; Matsuda I
    Arterioscler Thromb Vasc Biol; 1995 Jul; 15(7):956-62. PubMed ID: 7600128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed catabolism of high density lipoprotein apolipoproteins A-I and A-II in human cholesteryl ester transfer protein deficiency.
    Ikewaki K; Rader DJ; Sakamoto T; Nishiwaki M; Wakimoto N; Schaefer JR; Ishikawa T; Fairwell T; Zech LA; Nakamura H
    J Clin Invest; 1993 Oct; 92(4):1650-8. PubMed ID: 8408618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tangier disease: isolation and characterization of LpA-I, LpA-II, LpA-I: A-II and LpA-IV particles from plasma.
    Duchateau P; Rader D; Duverger N; Theret N; De Geitere C; Brewer HB; Fruchart JC; Castro GR
    Biochim Biophys Acta; 1993 Aug; 1182(1):30-6. PubMed ID: 8347683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human ApoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice.
    Zhong S; Goldberg IJ; Bruce C; Rubin E; Breslow JL; Tall A
    J Clin Invest; 1994 Dec; 94(6):2457-67. PubMed ID: 7989603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased esterification of cholesterol and transfer of cholesteryl ester to apo B-containing lipoproteins in Type 2 diabetes: relationship to serum lipoproteins A-I and A-II.
    Jones RJ; Owens D; Brennan C; Collins PB; Johnson AH; Tomkin GH
    Atherosclerosis; 1996 Jan; 119(2):151-7. PubMed ID: 8808492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High density lipoproteins with differing apolipoproteins: relationships to postprandial lipemia, cholesteryl ester transfer protein, and activities of lipoprotein lipase, hepatic lipase, and lecithin: cholesterol acyltransferase.
    Mowri HO; Patsch JR; Ritsch A; Föger B; Brown S; Patsch W
    J Lipid Res; 1994 Feb; 35(2):291-300. PubMed ID: 8169533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesterol efflux, cholesterol esterification, and cholesteryl ester transfer by LpA-I and LpA-I/A-II in native plasma.
    Huang Y; von Eckardstein A; Wu S; Assmann G
    Arterioscler Thromb Vasc Biol; 1995 Sep; 15(9):1412-8. PubMed ID: 7670956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased prebeta-HDL levels, cholesterol efflux, and LCAT-mediated esterification in mice expressing the human cholesteryl ester transfer protein (CETP) and human apolipoprotein A-I (apoA-I) transgenes.
    Francone OL; Royer L; Haghpassand M
    J Lipid Res; 1996 Jun; 37(6):1268-77. PubMed ID: 8808761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of gemfibrozil on the regulation of HDL subfractions in hypertriglyceridaemic patients.
    Kahri J; Sane T; van Tol A; Taskinen MR
    J Intern Med; 1995 Nov; 238(5):429-36. PubMed ID: 7595182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remodeling of HDL containing apoA-I but not apoA-II (LpA-I) by lipoprotein-deficient plasma and hepatic lipase: its effect on the structure and cellular cholesterol-reducing capacity of LpA-I.
    Ohta T; Ikeda Y; Hattori S; Matsuda I
    Biochim Biophys Acta; 1996 Sep; 1303(2):137-44. PubMed ID: 8856043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effect of subspecies of lipoprotein containing apolipoprotein A-I on cholesterol efflux from cholesterol-loaded macrophages: functional correlation with lecithin: cholesterol acyltransferase.
    Ohta T; Nakamura R; Ikeda Y; Shinohara M; Miyazaki A; Horiuchi S; Matsuda I
    Biochim Biophys Acta; 1992 Nov; 1165(1):119-28. PubMed ID: 1420341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between low-density lipoprotein size and apolipoprotein A-I-containing particles: the ECTIM study.
    Luc G; Bard JM; Poulain P; Arveiler D; Evans AE; Cambien F; Fruchart JC; Ducimetière P
    Eur J Clin Invest; 1997 Mar; 27(3):242-7. PubMed ID: 9088861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.